These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7946176)

  • 21. MIDAS: hypertension and atherosclerosis. A trial of the effects of antihypertensive drug treatment on atherosclerosis. MIDAS Research Group.
    Borhani NO; Miller ST; Brugger SB; Schnaper HW; Craven TE; Bond MG; Khoury S; Flack J
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S16-20. PubMed ID: 1376828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Multicenter Isradipine/Diuretic Atherosclerosis Study: a study of the antiatherogenic properties of isradipine in hypertensive patients. MIDAS Research Group.
    Borhani NO; Bond MG; Sowers JR; Canossa-Terris M; Buckalew V; Gibbons ME; Worthy AJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S15-9. PubMed ID: 1720479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter study with isradipine and diuretics against atherosclerosis. US MIDAS Research Group.
    Borhani NO; Brugger SB; Byington RP
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S23-9. PubMed ID: 1695298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac effects of isradipine in patients with hypertension.
    Lund-Johansen P
    Am J Hypertens; 1993 Jul; 6(7 Pt 2):294S-299S. PubMed ID: 8398014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative evaluation of the antihypertensive efficacy of once-daily sustained-release isradipine and lacidipine using 24-hour ambulatory blood-pressure monitoring.
    Galderisi M; Petrocelli A; Garofalo M; Celentano A; Alfieri A; de Divitiis O
    J Int Med Res; 1995; 23(4):234-43. PubMed ID: 7589766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. At equipotent doses, isradipine is better tolerated than amlodipine in patients with mild-to-moderate hypertension: a double-blind, randomized, parallel-group study.
    Hermans L; Deblander A; De Keyser P; Scheys I; Lesaffre E; Westelinck KJ
    Br J Clin Pharmacol; 1994 Oct; 38(4):335-40. PubMed ID: 7833223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative hemodynamic studies of isradipine and dihydralazine in atherosclerotic and normal rabbits.
    Hof RP; Hof A; Takiguchi Y
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S13-22. PubMed ID: 1695297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of the antihypertensive efficacy of isradipine SRO as assessed by ambulatory blood pressure determination].
    Waeber B; Soret P; Poget PN; Brunner HR
    Schweiz Rundsch Med Prax; 1992 Dec; 81(50):1514-7. PubMed ID: 1465521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isradipine decreases the hemodynamic response of cocaine and methamphetamine results from two human laboratory studies: results from two human laboratory studies.
    Johnson BA; Wells LT; Roache JD; Wallace C; Ait-Daoud N; Wang Y
    Am J Hypertens; 2005 Jun; 18(6):813-22. PubMed ID: 15925741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerability of isradipine in early Parkinson's disease: a pilot dose escalation study.
    Simuni T; Borushko E; Avram MJ; Miskevics S; Martel A; Zadikoff C; Videnovic A; Weaver FM; Williams K; Surmeier DJ
    Mov Disord; 2010 Dec; 25(16):2863-6. PubMed ID: 20818667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of diffusion-weighted MRI and neurological deficit scores to demonstrate beneficial effects of isradipine in a rat model of focal ischemia.
    Chandra S; White RF; Everding D; Feuerstein GZ; Coatney RW; Sarkar SK; Barone FC
    Pharmacology; 1999 Jun; 58(6):292-9. PubMed ID: 10325574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of slow-release oral isradipine in moderate-to-severe hypertension with add-on spirapril.
    Abarquez RF; Sy RG; Castillo RR
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):77S-79S. PubMed ID: 8466734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isradipine in hypertension.
    Hansson L
    Drugs; 1990; 40 Suppl 2():10-4. PubMed ID: 2150633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS).
    Applegate WB; Furberg CD; Byington RP; Grimm R
    JAMA; 1997 Jan 22-29; 277(4):297; author reply 297-8. PubMed ID: 9002488
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antihypertensive effect and adverse effects of isradipine in patients with sever hypertension. Results of an open multicenter study].
    Burger KJ; Dehner R
    Arzneimittelforschung; 1996 Jun; 46(6):600-5. PubMed ID: 8767350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The antihypertensive effect of isradipine and additional pharmacodynamic effects].
    Mayer O; Polívková H
    Vnitr Lek; 1993 Mar; 39(3):238-43. PubMed ID: 8506674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isradipine therapy in hypertensive pediatric patients.
    Johnson CE; Jacobson PA; Song MH
    Ann Pharmacother; 1997 Jun; 31(6):704-7. PubMed ID: 9184708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain MRI and neurological deficit measurements in focal stroke: rapid throughput validated with isradipine.
    Lenhard SC; Strittmatter R; Price WJ; Chandra S; White RF; Barone FC
    Pharmacology; 2008; 81(1):1-10. PubMed ID: 17726342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antiatherosclerotic effects of calcium antagonists.
    Paoletti R; Bernini F; Corsini A; Soma MR
    J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S6-10. PubMed ID: 8852538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS).
    Abt K
    JAMA; 1997 Jan 22-29; 277(4):297; author reply 297-8. PubMed ID: 9002487
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.